Skip to content
Screener

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$305M-15.5%
Eli Lilly logo
Eli LillyLLY
$2.93B+72.8%
Pfizer logo
PfizerPFE
$436M-22.7%
Amgen logo
AmgenAMGN
$513M+39.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$240.2M+9.7%
Biogen logo
BiogenBIIB
$40.9M+53.8%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.62B+145%
Enterprise value$1.37B+117%
P/S+1.6×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219515
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investments(122,547)
Sales and maturities of investments35,000137,429
Purchases of property and equipment(17)(35)
Net cash provided by investing activities34,98314,847
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock14,021290
Repurchase and retirements of common stock(4,424)

Item 1. Consolidated Financial Statements

FAQ

What is AnaptysBio, Inc.'s capex?
AnaptysBio, Inc. (ANAB) reported capex of $17K in Q1 2026.
How has AnaptysBio, Inc.'s capex changed year-over-year?
AnaptysBio, Inc.'s capex decreased by 51.4% year-over-year, from $35K to $17K.
What is the long-term trend for AnaptysBio, Inc.'s capex?
Over 4 years (2021 to 2025), AnaptysBio, Inc.'s capex has grown at a -49.8% compound annual growth rate (CAGR), from $1.37M to $87K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about AnaptysBio, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude